ciprofloxacin and beta-lactams

ciprofloxacin has been researched along with beta-lactams in 104 studies

Research

Studies (104)

Timeframe	Studies, this research(%)	All Research%
pre-1990	13 (12.50)	18.7374
1990's	12 (11.54)	18.2507
2000's	32 (30.77)	29.6817
2010's	32 (30.77)	24.3611
2020's	15 (14.42)	2.80

Authors

Authors	Studies
Bangsborg, J; Frimodt-Møller, N; Gutschik, E; Westh, H	1
Gordon, CA; Hodges, NA	1
Guenounou, M; Miguères, ML; Ronco, E	1
Dornbusch, K	1
Croize, J; Gout, JP; Le Noc, P; Robert, J	1
Bartlett, KH; Chow, AW; Shafran, SD; Stiver, HG; Wong, J	1
Chin, NX; Neu, HC	1
Chau, PY; Leung, YK; Lolekha, S; Ng, WS	1
Haller, I	1
Liu, S; Meyer, RD	2
Franke, JJ; Manion, FA; Stratton, CW; Weeks, LS	1
Bartlett, KH; Chow, AW; Wong, J	2
Gmeiner, J; Kroll, HP; Leying, H; Opferkuch, W; Suerbaum, S	1
Karch, H; Kroll, HP; Leying, H; Opferkuch, W; Suerbaum, S	1
Daikos, GL; Jackson, GG; Kathpalia, SB; Lolans, VT; Sharifi, R	1
Appelbaum, PC; Jacobs, MR; Pankuch, GA; Rittenhouse, SF	1
Hu, BS; Lau, YJ; Lin, YH; Liu, PY; Shi, ZY; Shyr, JM; Tsai, WS; Tseng, CY	1
Andrews, JM; Brenwald, N; Wise, R	1
Cavallo, JD; Dubrous, P; Fabre, R; Hernandez, E; Nordmann, P	1
Bello, H; Dominguez, M; Garcia, A; Gonzalez, G; Mella, S; Zemelman, R	1
Aguilar, C; Carnalla, N; Echániz, G; Estrada, MA; López-Antuñano, FJ; Silva, J; Soto, A	1
Alperstein, P; France, K; Isenberg, HD	1
Espasa, M; Gómez-Martínez, J; Jiménez de Anta, MT; Marco, F; Martínez, JA; Mensa, J	1
Andriole, VT; Bassetti, M; Callan, DA; Dembry, LM; Farrel, PA	1
Jones, RN; Pfaller, MA	1
Carryn, S; Mingeot-Leclercq, MP; Tulkens, PM; Van Bambeke, F	1
Bartizal, K; Gesser, RM; Motyl, M; Pelak, BA; Woods, GL	1
Behra-Miellet, J; Dubreuil, L; Jumas-Bilak, E	1
Gendrel, D; Lorrot, MM; Marc, E; Moulin, F; Ravilly, S; Raymond, J; Sauvé-Martin, H; Soulier, M	1
Johnson, MM; Piddock, LJ; Webber, MA	1
Harigae, H; Ishikawa, S; Kaku, M; Kanemitsu, K; Kunishima, H; Saga, T; Takemura, H	1
Bertrand, X; Lallemand-De-Conto, S; Talon, D; Thouverez, M	1
Bonten, MJ; Florijn, A; Fluit, AC; Nijssen, S; Schmitz, FJ; Verhoef, J	1
Burgess, DS; Frei, CR; Moczygemba, LR	1
Evangelista, AT; Jones, ME; Karlowsky, JA; Sahm, DF; Thornsberry, C; Yee, YC	1
De Vecchi, E; Drago, L; Gismondo, MR; Nicola, L; Tocalli, L	1
Leibovici, L; Paul, M	1
Bliziotis, IA; Christodoulou, C; Chrysanthopoulou, S; Falagas, ME; Kasiakou, SK; Michalopoulos, A; Samonis, G	1
Amicosante, G; Becerro, P; De Anta, MT; Perilli, M; Ruiz, J; Tavío, MM; Vila, J	1
Lipman, J; Roberts, JA	1
Bliziotis, IA; Falagas, ME; Matthaiou, DK; Peppas, G	1
Devreese, K; Leus, B; Malfait, R; van den Bossche, J	1
Momary, KM; Pai, MP; Rodvold, KA	1
Li, JT; Markus, P; Matesic, D; Park, M	1
Shinagawa, N; Takeyama, H; Taniguchi, M; Yura, J	1
Galani, I; Giamarellos-Bourboulis, EJ; Giamarellou, H; Kanellakopoulou, K; Sarafis, P	1
Berta, J; Damjanova, I; Füzi, M; Hajbel-Vékony, G; Jakab, M; Milch, H; Pászti, J; Tóth, A	1
Ba, T; Gao, BQ; Li, YY; Ma, WH; Meng, ZY; Wang, LF; Wang, XD; Yu, QP; Zhang, J; Zhang, LH	1
Amicosante, G; Celenza, G; Forcella, C; Frascaria, P; Pellegrini, C; Perilli, M; Segatore, B	1
Basuino, L; Chambers, HF; Tattevin, P	1
Almela, M; López, J; López-Dupla, M; Marco, F; Martínez, JA; Mensa, J; Olona, M; Soriano, A; Vidal, F	1
Badri, M; Donaghy, P; Karisik, E; Livermore, DM; Loughrey, AC; McCalmont, M; O'Leary, MC; Rooney, PJ; Smyth, B; Woodford, N	1
Ermertcan, S; Hosgor-Limoncu, M; Tasli, H; Yurtman, AN	1
Ablij, HC; Assendelft, WJ; Blom, JW; Delfos, NM; Elzevier, HW; Koster, T; Kuijper, EJ; Leyten, EM; Pander, J; Spelt, IC; van Dissel, JT; van Nieuwkoop, C; van't Wout, JW; Wattel-Louis, GH	1
Lee, HJ; Lee, KM; Suh, JT; Yang, HY	1
Ikeda, F; Ishii, Y; Iyoda, T; Kanayama, A; Kobayashi, I; Matsuzaki, K; Saika, T; Yamaguchi, K	1
Brandão, AP; Brandileone, MC; de Paiva, MV; Gorla, MC; Lemos, AP; Salgueiro, VC; Vázquez, JA	1
Andersohn, F; Bronder, E; Garbe, E; Grüneisen, A; Hildebrandt, M; Klimpel, A; Kurtal, H; Mayer, B; Salama, A; Schrezenmeier, H; Späth-Schwalbe, E; Thomae, M	1
Chiu, CH; Su, LH; Wu, TL	1
Ezoe, T; Ishiyama, M; Matsumoto, K; Noguchi, K; Shiga, M; Suenaga, H; Tsukatani, T	1
Gruszczyńska, B; Kaznowski, A; Mokracka, J	1
Bonomo, RA; Donskey, CJ; Drawz, PE; Hirsch, AA; Jump, RL; Jury, LA; Kypriotakis, G; Olds, DM; Peron, EP; Seifi, N; Watts, B	1
Bou, G; Castelo-Corral, L; Gutiérrez-Urbón, JM; Llinares, P; López-Calviño, B; Molina, F; Sousa, D	1
Ciofu, O; Hengzuang, W; Høiby, N; Jensen, PØ; Jørgensen, KM; Molin, S; Wassermann, T	1
Fabry, WH; Kock, HJ; Vahlensieck, W	1
Belghiti, J; Bert, F; Dondero, F; Durand, F; Larroque, B; Moreau, R; Nicolas-Chanoine, MH; Paugam-Burtz, C	1
Blackmore, T; Losco, G; Studd, R	1
Bowler, IC; Buchanan, R; Crook, D; Stoesser, N	1
Anderson, RC; Andrews, K; Beier, RC; Bodeis-Jones, S; Crippen, TL; Davidson, MK; Foley, SL; McDermott, PF; Nisbet, DJ; Poole, TL; Sheffield, CL; White, DG; Zhao, S	1
Badal, RE; Cao, B; Chen, S; Chu, Y; Duan, Q; Feng, X; Gui, B; Hu, B; Hu, Z; Huang, W; Kong, H; Liao, K; Luo, Y; Ni, Y; Shao, H; Su, J; Sun, Z; Wang, Y; Wu, A; Xu, Y; Yang, Q; Yu, Y; Zhang, H; Zhang, S	1
Baker-Austin, C; Fletcher, DE; McArthur, JV; Tuckfield, RC	1
Galarza, P; Gianecini, R; Guantay, C; Oviedo, C; Piccoli, L; Stafforini, G	1
Davies, HA; Garamus, VM; Gorniak, T; Hilpert, K; Mikut, R; Reischl, M; Rosenhahn, A; von Gundlach, AR	1
Ammenouche, N; Castelain, S; Choquet, M; Decroix, V; Guiheneuf, R; Pluquet, E	1
Brul, S; Feng, Y; Jonker, MJ; Moustakas, I; Ter Kuile, BH	1
Banerjee, R; Boyce, TG; Cunningham, SA; Hasassri, ME; Jeraldo, PR; Kaye, KS; Norgan, AP; Patel, R; Pogue, JM; Weissman, SJ	1
Álvarez, C; Ardila, N; Ariza, B; Caro, MA; Gil, F; González, PF; Valderrama, SL	1
Abdel-Haq, N; Ang, JY; Nicolau, DP; Satlin, MJ; Thabit, AK; van Duin, D; Zhu, F	1
Barkham, TM; Chen, H; Gin, KY; Koh, TH; Le, TH; Ng, C; Yi, XZ; Zhou, Z	1
Bader, M; Seitz, M; Stief, C; Tilki, D; Waidelich, R	1
Ha, DT; Ho-Le, TP; Hoang, HQ; Nguyen, DA; Nguyen, TA; Nguyen, TSM; Nguyen, TV; Pham, TTN; Tran, GM; Tran, NV; Tran-Nguyen, CH	1
Coll, P; Espinal, P; Gómez, L; Miró, E; Navarro, F; Plasencia, V; Segura, C	1
Auerbach, AD; Dvorak, CC; Levy, ER; Sabnis, AJ; Wattier, RL	1
Chen, CJ; Chuang, YY; Huang, YC; Ko, WC; Lauderdale, TY; Lee, CY; Lu, CT; Lu, MC; Wu, TS; Yang, CC	1
Fung, CP; Lin, YT; Wang, FD; Wu, PF; Yang, TC	1
Caetano, T; Covas, C; Mendo, S; Santos, T; Viana, AT	1
McLaughlin, HP; Sue, D	1
Nakagawa, Y; Sai, Y; Shimada, T; Suga, Y; Suzuki, T	1
Kaur, S; Rashid, M; Sharma, P	1
Ariza, J; Benavent, E; Cabo, X; Gómez-Junyent, J; Murillo, O; Padullés, A; Rigo-Bonnin, R; Soldevila, L; Tubau, F	1
Gillani, SSA; Kanwal, Z; Malik, H; Pervaiz, I; Rafique, M; Rashid, F	1
Carolan, JC; Margalit, A; Walsh, F	1
Abaza, M; Aboubakr, M; Awad, D; Edris, S; Fouad, M; Hamad, A; Hussein, A; Nabil, M; Ramadan, H; Sabeq, I; Shama, S	1
Abdulla, A; Bahmany, S; Endeman, H; Ewoldt, TMJ; Gommers, D; Hunfeld, N; Koch, BCP; Muller, AE; Polinder, S; Spronk, I; van den Broek, P	1
Goytia, M; Wadsworth, CB	1
Alispahic, IA; Andreassen, HF; Armbruster, K; Bangsborg, J; Bodtger, U; Browatzki, A; Christensen, CW; Coia, JE; Datcu, R; Eklöf, J; Ellingsgaard, T; Fenlev, CS; Ghathian, KSA; Gundersen, L; Harboe, ZB; Heidemann, M; Janner, J; Jensen, JUS; Jensen, TT; Johansson, SL; Johnsen, S; Kjærgaard, JL; Lapperre, TS; Linde, H; Moberg, M; Nielsen, TL; Overgaard, RH; Pedersen, L; Rosenvinge, FS; Saeed, MI; Seersholm, N; Sivapalan, P; Sørensen, VM; Titlestad, I; Ulrik, CS; Vijdea, R; Weinreich, UM; Wilcke, T; Østergaard, C	1
Bower, WA; Bulitta, JB; Chatham-Stephens, K; Cook, R; Hendricks, K; Kennedy, JL; Mongkolrattanothai, T; Negron, ME; Person, MK; Shin, E; Yu, P	1
Abdulla, A; de Winter, BCM; Draisma, A; Endeman, H; Ewoldt, TMJ; Gommers, D; Haringman, J; Hunfeld, NGM; Karakus, A; Koch, BCP; Muller, AE; Purmer, IM; Rietdijk, WJR; Rijpstra, TA; van Vliet, P; Wils, EJ	1
Kepiro, I; Pagliara, S; Ryadnov, MG; Zhang, Y	1
Angelov, A; Bohn, E; Borisova, M; Eggers, O; Egle, V; Engesser, C; Klein, K; Mayer, C; Michalek, LA; Renschler, FA; Schütz, M; Smollich, F; Sonnabend, MS; Wackler, N; Walter, E	1
Aydiner, C; Ikizoglu, B; Kanat, G; Turkdogan, FI	1
Braetz, S; Figueroa-Bossi, N; Fulde, M; Schwerk, P; Tedin, K	1

Reviews

6 review(s) available for ciprofloxacin and beta-lactams

Article	Year
Ciprofloxacin vs an aminoglycoside in combination with a beta-lactam for the treatment of febrile neutropenia: a meta-analysis of randomized controlled trials. Mayo Clinic proceedings, 2005, Volume: 80, Issue:9 Topics: Aminoglycosides; Anti-Bacterial Agents; beta-Lactams; Ciprofloxacin; Drug Therapy, Combination; Fever; Humans; Neoplasms; Neutropenia; Randomized Controlled Trials as Topic; Treatment Outcome	2005
Antibacterial dosing in intensive care: pharmacokinetics, degree of disease and pharmacodynamics of sepsis. Clinical pharmacokinetics, 2006, Volume: 45, Issue:8 Topics: Aminoglycosides; Anti-Bacterial Agents; Bacteria; beta-Lactams; Ciprofloxacin; Critical Care; Drug Administration Schedule; Drug Monitoring; Humans; Sepsis; Vancomycin	2006
Ciprofloxacin/metronidazole versus beta-lactam-based treatment of intra-abdominal infections: a meta-analysis of comparative trials. International journal of antimicrobial agents, 2006, Volume: 28, Issue:3 Topics: Abdomen; Anti-Bacterial Agents; Bacterial Infections; beta-Lactams; Ciprofloxacin; Drug Therapy, Combination; Humans; Metronidazole; PubMed; Randomized Controlled Trials as Topic	2006
Antibiotic drug interactions. The Medical clinics of North America, 2006, Volume: 90, Issue:6 Topics: Aminoglycosides; Anti-Bacterial Agents; Antitubercular Agents; Antiviral Agents; ATP Binding Cassette Transporter, Subfamily B, Member 1; beta-Lactams; Chloramphenicol; Ciprofloxacin; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Drug Interactions; Fluoroquinolones; Gastrointestinal Tract; Histamine H2 Antagonists; Humans; Influenza A virus; Macrolides; Pharmacokinetics; Tetracyclines	2006
Canary in the Coal Mine: How Resistance Surveillance in Commensals Could Help Curb the Spread of AMR in Pathogenic mBio, 2022, 10-26, Volume: 13, Issue:5 Topics: Anti-Bacterial Agents; Anti-Infective Agents; Azithromycin; beta-Lactams; Ciprofloxacin; DNA Gyrase; Drug Resistance, Bacterial; Gonorrhea; Humans; Microbial Sensitivity Tests; Neisseria; Neisseria gonorrhoeae; Penicillin-Binding Proteins	2022
Postexposure Prophylaxis and Treatment of Bacillus anthracis Infections: A Systematic Review and Meta-analyses of Animal Models, 1947-2019. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2022, 10-17, Volume: 75, Issue:Suppl 3 Topics: Amoxicillin-Potassium Clavulanate Combination; Animals; Anthrax; Anti-Bacterial Agents; Anti-Infective Agents; Bacillus anthracis; beta-Lactams; Cilastatin, Imipenem Drug Combination; Ciprofloxacin; Doxycycline; Glycopeptides; Humans; Levofloxacin; Lipopeptides; Models, Animal; Tetracyclines; United States	2022

Trials

7 trial(s) available for ciprofloxacin and beta-lactams

Article	Year
Resistance to beta-lactam antibiotics and ciprofloxacin in gram-negative bacilli and staphylococci isolated from blood: a European collaborative study. European Study Group on Antibiotic Resistance. The Journal of antimicrobial chemotherapy, 1990, Volume: 26, Issue:2 Topics: Ampicillin Resistance; Anti-Bacterial Agents; beta-Lactams; Ciprofloxacin; Drug Resistance, Microbial; Escherichia coli; Europe; Gram-Negative Bacteria; Humans; Microbial Sensitivity Tests; Penicillin Resistance; Pseudomonas; Staphylococcus aureus	1990
Comparison of ciprofloxacin and beta-lactam antibiotics in the treatment of urinary tract infections and alteration of fecal flora. The American journal of medicine, 1987, Apr-27, Volume: 82, Issue:4A Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacterial Infections; beta-Lactams; Ciprofloxacin; Clinical Trials as Topic; Drug Resistance, Microbial; Feces; Female; Gram-Negative Aerobic Bacteria; Humans; Intestines; Male; Middle Aged; Urinary Tract Infections	1987
[Ciprofloxacin after clinical failure of beta-lactam antibiotics in children with salmonellosis]. Archives de pediatrie : organe officiel de la Societe francaise de pediatrie, 2003, Volume: 10, Issue:7 Topics: Administration, Oral; Adolescent; Anti-Bacterial Agents; Anti-Infective Agents; beta-Lactams; Child; Child, Preschool; Ciprofloxacin; Drug Resistance, Microbial; Female; Humans; Infant; Male; Salmonella Infections; Treatment Outcome	2003
Treatment duration of febrile urinary tract infection (FUTIRST trial): a randomized placebo-controlled multicenter trial comparing short (7 days) antibiotic treatment with conventional treatment (14 days). BMC infectious diseases, 2009, Aug-19, Volume: 9 Topics: Anti-Bacterial Agents; beta-Lactams; Ciprofloxacin; Double-Blind Method; Female; Fever; Gentamicins; Humans; Male; Urinary Tract Infections	2009
Effective antimicrobial stewardship in a long-term care facility through an infectious disease consultation service: keeping a LID on antibiotic use. Infection control and hospital epidemiology, 2012, Volume: 33, Issue:12 Topics: Anti-Bacterial Agents; Anti-Infective Agents; beta-Lactams; Ciprofloxacin; Clindamycin; Clostridioides difficile; Enterocolitis, Pseudomembranous; Humans; Infectious Disease Medicine; Long-Term Care; Nitrofurantoin; Nursing Homes; Referral and Consultation; Regression Analysis; Tetracyclines; Trimethoprim, Sulfamethoxazole Drug Combination; Vancomycin	2012
Targeted AntiBiotics for Chronic pulmonary diseases (TARGET ABC): can targeted antibiotic therapy improve the prognosis of Pseudomonas aeruginosa-infected patients with chronic pulmonary obstructive disease, non-cystic fibrosis bronchiectasis, and asthma? Trials, 2022, Sep-27, Volume: 23, Issue:1 Topics: Anti-Bacterial Agents; Asthma; beta-Lactams; Bronchiectasis; Ciprofloxacin; Fibrosis; Humans; Prednisolone; Prognosis; Pseudomonas aeruginosa; Pulmonary Disease, Chronic Obstructive	2022
Model-informed precision dosing of beta-lactam antibiotics and ciprofloxacin in critically ill patients: a multicentre randomised clinical trial. Intensive care medicine, 2022, Volume: 48, Issue:12 Topics: Anti-Bacterial Agents; beta-Lactams; Ciprofloxacin; Critical Illness; Humans; Intensive Care Units; Middle Aged; Monobactams	2022

Other Studies

91 other study(ies) available for ciprofloxacin and beta-lactams

Article	Year
Killing curve activity of ciprofloxacin is comparable to synergistic effect of beta-lactam-tobramycin combinations against Haemophilus species endocarditis strains. APMIS : acta pathologica, microbiologica, et immunologica Scandinavica, 1992, Volume: 100, Issue:9 Topics: Anti-Bacterial Agents; beta-Lactams; Ciprofloxacin; Drug Synergism; Endocarditis, Bacterial; Haemophilus; Humans; Microbial Sensitivity Tests; Tobramycin	1992
Protection of Pseudomonas aeruginosa against ciprofloxacin and beta-lactams by homologous alginate. Antimicrobial agents and chemotherapy, 1991, Volume: 35, Issue:11 Topics: Alginates; Anti-Bacterial Agents; beta-Lactams; Ciprofloxacin; Cystic Fibrosis; Humans; Microbial Sensitivity Tests; Polysaccharides; Pseudomonas aeruginosa	1991
[In vitro activity of 4 fluoroquinolones against Klebsiella pneumoniae. Distribution according to phenotype resistance to aminoglycosides or beta-lactams]. Pathologie-biologie, 1990, Volume: 38, Issue:5 Topics: Aminoglycosides; Anti-Bacterial Agents; beta-Lactams; Ciprofloxacin; Dose-Response Relationship, Drug; Drug Resistance, Microbial; In Vitro Techniques; Klebsiella pneumoniae; Norfloxacin; Ofloxacin; Pefloxacin; Phenotype	1990
[In vitro effect of various antibiotics: beta lactams, aminoglycosides and fluoroquinolones alone and in combination against P. aeruginosa isolated from patients with mucoviscidosis]. Pathologie-biologie, 1989, Volume: 37, Issue:5 Pt 2 Topics: Aminoglycosides; Anti-Bacterial Agents; beta-Lactams; Ciprofloxacin; Cystic Fibrosis; Drug Resistance, Microbial; Drug Therapy, Combination; Humans; Ofloxacin; Pseudomonas aeruginosa	1989
Cross-resistance of Pseudomonas aeruginosa to ciprofloxacin, extended-spectrum beta-lactams, and aminoglycosides and susceptibility to antibiotic combinations. Antimicrobial agents and chemotherapy, 1989, Volume: 33, Issue:8 Topics: Aminoglycosides; Anti-Bacterial Agents; Anti-Infective Agents; beta-Lactams; Ciprofloxacin; Drug Resistance, Microbial; Drug Therapy, Combination; Microbial Sensitivity Tests; Pseudomonas aeruginosa	1989
In-vitro activity of FCE 22101 and synergy studies with other antimicrobial agents. The Journal of antimicrobial chemotherapy, 1989, Volume: 23 Suppl C Topics: Anti-Bacterial Agents; Bacteria; Bacterial Infections; beta-Lactamase Inhibitors; beta-Lactamases; beta-Lactams; Carbapenems; Ciprofloxacin; Drug Resistance, Microbial; Drug Synergism; Gentamicins; Gram-Positive Bacteria; Microbial Sensitivity Tests	1989
In vitro susceptibility of strains of Pseudomonas pseudomallei isolated in Thailand and Hong Kong to some newer beta-lactam antibiotics and quinolone derivatives. The Journal of infectious diseases, 1986, Volume: 153, Issue:1 Topics: Anti-Bacterial Agents; beta-Lactams; Ciprofloxacin; Hong Kong; Humans; Microbial Sensitivity Tests; Ofloxacin; Oxazines; Pseudomonas; Quinolines; Thailand	1986
Comprehensive evaluation of ciprofloxacin in combination with beta-lactam antibiotics against Enterobacteriaceae and Pseudomonas aeruginosa. Arzneimittel-Forschung, 1986, Volume: 36, Issue:2 Topics: Animals; Anti-Bacterial Agents; Bacterial Infections; beta-Lactams; Ciprofloxacin; Drug Synergism; Enterobacteriaceae; Male; Mice; Muscles; Pseudomonas aeruginosa; Quinolines; Time Factors	1986
In vitro activity of aryl fluoroquinolones, Abbott 56619 and Abbott 56620, compared to ciprofloxacin, norfloxacin and beta-lactams versus multidrug-resistant Enterobacteriaceae and Pseudomonas aeruginosa. Chemotherapy, 1986, Volume: 32, Issue:5 Topics: Anti-Bacterial Agents; beta-Lactams; Ciprofloxacin; Enterobacteriaceae; Fluoroquinolones; Microbial Sensitivity Tests; Norfloxacin; Pseudomonas aeruginosa	1986
Comparison of the bactericidal activity of ciprofloxacin alone and in combination with selected antipseudomonal beta-lactam agents against clinical isolates of Pseudomonas aeruginosa. Diagnostic microbiology and infectious disease, 1988, Volume: 11, Issue:1 Topics: Anti-Bacterial Agents; beta-Lactams; Ciprofloxacin; Drug Stability; Drug Synergism; Drug Therapy, Combination; Kinetics; Microbial Sensitivity Tests; Pseudomonas aeruginosa	1988
In vitro synergy studies with ciprofloxacin and selected beta-lactam agents and aminoglycosides against multidrug-resistant Pseudomonas aeruginosa. Diagnostic microbiology and infectious disease, 1988, Volume: 11, Issue:3 Topics: Aminoglycosides; Anti-Bacterial Agents; beta-Lactams; Ciprofloxacin; Drug Resistance, Microbial; Drug Synergism; Microbial Sensitivity Tests; Pseudomonas aeruginosa	1988
Synergistic interactions of ciprofloxacin and extended spectrum beta-lactams or aminoglycosides against Acinetobacter calcoaceticus ss. anitratus. Diagnostic microbiology and infectious disease, 1988, Volume: 9, Issue:4 Topics: Acinetobacter; Aminoglycosides; Anti-Bacterial Agents; beta-Lactams; Ciprofloxacin; Drug Synergism; Humans; Microbial Sensitivity Tests	1988
Influence of beta-lactam antibiotics and ciprofloxacin on cell envelope of Escherichia coli. Antimicrobial agents and chemotherapy, 1987, Volume: 31, Issue:7 Topics: Amino Acids; Anti-Bacterial Agents; Antigens, Bacterial; Bacterial Capsules; beta-Lactams; Cell Membrane; Ciprofloxacin; Diaminopimelic Acid; Escherichia coli; Lipid Metabolism; Phospholipids; Polysaccharides, Bacterial; Sugar Acids	1987
Synergistic interactions of ciprofloxacin and extended-spectrum beta-lactams or aminoglycosides against multiply drug-resistant Pseudomonas maltophilia. Antimicrobial agents and chemotherapy, 1988, Volume: 32, Issue:5 Topics: Aminoglycosides; Anti-Bacterial Agents; beta-Lactams; Ciprofloxacin; Drug Resistance, Microbial; Drug Synergism; Humans; Microbial Sensitivity Tests; Pseudomonas	1988
Influence of beta-lactam antibiotics and ciprofloxacin on composition and immunogenicity of Escherichia coli outer membrane. Antimicrobial agents and chemotherapy, 1986, Volume: 30, Issue:3 Topics: Animals; Anti-Bacterial Agents; Antibody-Producing Cells; beta-Lactams; Cell Membrane; Centrifugation, Density Gradient; Ciprofloxacin; Escherichia coli; Hemolytic Plaque Technique; Lipopolysaccharides; Mice; Microbial Sensitivity Tests; Phospholipids	1986
Susceptibilities of 123 strains of Xanthomonas maltophilia to eight beta-lactams (including beta-lactam-beta-lactamase inhibitor combinations) and ciprofloxacin tested by five methods. Antimicrobial agents and chemotherapy, 1994, Volume: 38, Issue:10 Topics: Anti-Bacterial Agents; beta-Lactamase Inhibitors; beta-Lactams; Ciprofloxacin; Drug Resistance, Microbial; Microbial Sensitivity Tests; Xanthomonas	1994
Comparison of susceptibility to extended-spectrum beta-lactam antibiotics and ciprofloxacin among gram-negative bacilli isolated from intensive care units. Diagnostic microbiology and infectious disease, 1995, Volume: 22, Issue:3 Topics: Anti-Bacterial Agents; Anti-Infective Agents; beta-Lactams; Ciprofloxacin; Cross Infection; Drug Resistance, Microbial; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Intensive Care Units; Microbial Sensitivity Tests	1995
In vitro activity of the tricyclic beta-lactam GV104326. Antimicrobial agents and chemotherapy, 1996, Volume: 40, Issue:5 Topics: Amoxicillin; Anti-Bacterial Agents; Anti-Infective Agents; beta-Lactams; Cefuroxime; Ciprofloxacin; Haemophilus influenzae; Lactams; Microbial Sensitivity Tests; Moraxella catarrhalis; Streptococcus pneumoniae	1996
[Pseudomonas aeruginosa: bactericidal activity on various beta-lactam resistance phenotypes of 8 antibiotics and 7 combinations]. Pathologie-biologie, 1997, Volume: 45, Issue:5 Topics: Amikacin; Anti-Bacterial Agents; Anti-Infective Agents; beta-Lactam Resistance; beta-Lactams; Ciprofloxacin; Drug Therapy, Combination; In Vitro Techniques; Phenotype; Pseudomonas aeruginosa	1997
Activity of selected beta-lactams, ciprofloxacin, and amikacin against different Acinetobacter baumannii biotypes from Chilean hospitals. Diagnostic microbiology and infectious disease, 1997, Volume: 28, Issue:4 Topics: Acinetobacter; Acinetobacter Infections; Amikacin; Anti-Bacterial Agents; Anti-Infective Agents; Bacterial Typing Techniques; beta-Lactam Resistance; beta-Lactams; Chile; Ciprofloxacin; Cross Infection; Drug Resistance, Multiple; Humans; Microbial Sensitivity Tests; Multicenter Studies as Topic	1997
Susceptibility to new beta-lactams of enterobacterial extended-spectrum beta-lactamase (ESBL) producers and penicillin-resistant Streptococcus pneumoniae in Mexico. Journal of chemotherapy (Florence, Italy), 1998, Volume: 10, Issue:2 Topics: Aminoglycosides; Anti-Bacterial Agents; Anti-Infective Agents; beta-Lactamases; beta-Lactams; Cephalosporin Resistance; Ciprofloxacin; Colony Count, Microbial; Enterobacteriaceae; Mexico; Penicillin Resistance; Streptococcus pneumoniae	1998
In vitro activity of ciprofloxacin, levofloxacin, and trovafloxacin, alone and in combination with beta-lactams, against clinical isolates of Pseudomonas aeruginosa, Stenotrophomonas maltophilia, and Burkholderia cepacia. Diagnostic microbiology and infectious disease, 1999, Volume: 33, Issue:2 Topics: Anti-Infective Agents; beta-Lactams; Burkholderia cepacia; Ciprofloxacin; Fluoroquinolones; Humans; Levofloxacin; Naphthyridines; Ofloxacin; Pseudomonas aeruginosa; Xanthomonas	1999
[In vitro activity of fluoroquinolones and oral beta lactam antibiotics against clinical isolates of Escherichia coli]. Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia, 1999, Volume: 12, Issue:1 Topics: Administration, Oral; Anti-Bacterial Agents; Anti-Infective Agents; beta-Lactams; Ciprofloxacin; Escherichia coli; Fluoroquinolones; Humans; Microbial Sensitivity Tests	1999
Comparative antimicrobial activity of gatifloxacin with ciprofloxacin and beta-lactams against gram-positive bacteria. Diagnostic microbiology and infectious disease, 2001, Volume: 41, Issue:3 Topics: Anti-Bacterial Agents; Anti-Infective Agents; beta-Lactams; Ciprofloxacin; Enterococcus; Fluoroquinolones; Gatifloxacin; Gram-Positive Bacteria; Humans; Microbial Sensitivity Tests; Staphylococcus; Streptococcus	2001
Ciprofloxacin as broad-spectrum empiric therapy--are fluoroquinolones still viable monotherapeutic agents compared with beta-lactams: data from the MYSTIC Program (US)? Diagnostic microbiology and infectious disease, 2002, Volume: 42, Issue:3 Topics: Anti-Bacterial Agents; beta-Lactams; Ciprofloxacin; Drug Resistance, Bacterial; Drug Resistance, Multiple, Bacterial; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Microbial Sensitivity Tests; United States	2002
Comparative intracellular (THP-1 macrophage) and extracellular activities of beta-lactams, azithromycin, gentamicin, and fluoroquinolones against Listeria monocytogenes at clinically relevant concentrations. Antimicrobial agents and chemotherapy, 2002, Volume: 46, Issue:7 Topics: Anti-Bacterial Agents; Anti-Infective Agents; Aza Compounds; Azithromycin; beta-Lactams; Ciprofloxacin; Fluoroquinolones; Gentamicins; Humans; Listeria monocytogenes; Macrophages; Microbial Sensitivity Tests; Moxifloxacin; Quinolines	2002
Comparative in vitro activities of ertapenem against aerobic and facultative bacterial pathogens from patients with complicated skin and skin structure infections. Diagnostic microbiology and infectious disease, 2002, Volume: 43, Issue:2 Topics: Aerobiosis; Anti-Bacterial Agents; beta-Lactams; Ciprofloxacin; Drug Resistance, Multiple, Bacterial; Ertapenem; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Humans; Lactams; Microbial Sensitivity Tests; Skin Diseases, Bacterial	2002
Antianaerobic activity of moxifloxacin compared with that of ofloxacin, ciprofloxacin, clindamycin, metronidazole and beta-lactams. International journal of antimicrobial agents, 2002, Volume: 20, Issue:5 Topics: Anaerobiosis; Anti-Bacterial Agents; Aza Compounds; Bacterial Infections; beta-Lactams; Ciprofloxacin; Clindamycin; Fluoroquinolones; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Metronidazole; Microbial Sensitivity Tests; Moxifloxacin; Ofloxacin; Quinolines	2002
Activity of faropenem and imipenem for ciprofloxacin-resistant bacteria. The Journal of antimicrobial chemotherapy, 2003, Volume: 52, Issue:3 Topics: Anti-Bacterial Agents; Bacteria; Bacterial Infections; beta-Lactams; Ciprofloxacin; Drug Resistance, Bacterial; Humans; Imipenem; Lactams; Microbial Sensitivity Tests; Mutation; Nalidixic Acid; Phenotype; Reverse Transcriptase Polymerase Chain Reaction; Thienamycins	2003
Efficacy of amikacin combinations for nocardiosis. The Tohoku journal of experimental medicine, 2003, Volume: 201, Issue:3 Topics: Adult; Aged; Aged, 80 and over; Amikacin; Anti-Bacterial Agents; beta-Lactams; Cefotaxime; Ciprofloxacin; DNA, Ribosomal; Drug Therapy, Combination; Erythromycin; Female; Fluoroquinolones; Gram-Positive Bacteria; Humans; Imipenem; Lactams; Male; Middle Aged; Minocycline; Nocardia; Nocardia Infections; RNA, Ribosomal, 16S; Streptomyces; Sulfamethoxazole; Trimethoprim	2003
[E. coli: resistance to quinolones and beta-lactams of clinical strains isolated in the Franche-Comté region of France]. Pathologie-biologie, 2004, Volume: 52, Issue:2 Topics: Adult; Aged; Amoxicillin; Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactams; Ceftazidime; Cephalothin; Ciprofloxacin; Clavulanic Acid; Community-Acquired Infections; Cross Infection; DNA, Bacterial; Drug Resistance, Multiple, Bacterial; Drug Utilization; Escherichia coli; Escherichia coli Infections; Female; Fluoroquinolones; France; Genotype; Humans; Male; Middle Aged; Nalidixic Acid; Phenotype; Selection, Genetic; Urinary Tract Infections	2004
Beta-lactam susceptibilities and prevalence of ESBL-producing isolates among more than 5000 European Enterobacteriaceae isolates. International journal of antimicrobial agents, 2004, Volume: 24, Issue:6 Topics: Aztreonam; beta-Lactam Resistance; beta-Lactamase Inhibitors; beta-Lactamases; beta-Lactams; Cephalosporins; Ciprofloxacin; Enterobacteriaceae; Enterobacteriaceae Infections; Europe; Humans; Klebsiella; Klebsiella Infections; Microbial Sensitivity Tests	2004
Pharmacodynamic modeling of carbapenems and fluoroquinolones against bacteria that produce extended-spectrum beta-lactamases. Clinical therapeutics, 2004, Volume: 26, Issue:11 Topics: Anti-Bacterial Agents; beta-Lactamases; beta-Lactams; Carbapenems; Ciprofloxacin; Drug Resistance, Bacterial; Ertapenem; Escherichia coli; Fluoroquinolones; Gatifloxacin; Humans; Imipenem; Klebsiella pneumoniae; Lactams; Levofloxacin; Meropenem; Microbial Sensitivity Tests; Models, Biological; Monte Carlo Method; Ofloxacin; Thienamycins	2004
Stable antimicrobial susceptibility rates for clinical isolates of Pseudomonas aeruginosa from the 2001-2003 tracking resistance in the United States today surveillance studies. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2005, Feb-15, Volume: 40 Suppl 2 Topics: beta-Lactams; Ceftazidime; Ciprofloxacin; Drug Resistance, Multiple, Bacterial; Fluoroquinolones; Gatifloxacin; Gentamicins; Humans; Microbial Sensitivity Tests; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Pseudomonas aeruginosa; Pseudomonas Infections; United States	2005
In vitro selection of resistance in Pseudomonas aeruginosa and Acinetobacter spp. by levofloxacin and ciprofloxacin alone and in combination with beta-lactams and amikacin. The Journal of antimicrobial chemotherapy, 2005, Volume: 56, Issue:2 Topics: Acinetobacter; Amikacin; Anti-Bacterial Agents; beta-Lactams; Ciprofloxacin; Drug Resistance, Multiple, Bacterial; Drug Therapy, Combination; Levofloxacin; Microbial Sensitivity Tests; Mutation; Ofloxacin; Pseudomonas aeruginosa	2005
Systematic reviews and meta-analysis of febrile neutropenia. Mayo Clinic proceedings, 2005, Volume: 80, Issue:9 Topics: Aminoglycosides; Anti-Bacterial Agents; beta-Lactams; Ciprofloxacin; Drug Therapy, Combination; Fever; Humans; Meta-Analysis as Topic; Neoplasms; Neutropenia; Reproducibility of Results; Review Literature as Topic; Treatment Outcome	2005
Ciprofloxacin, salicylate, and 2,4-dinitrophenol decrease production of AmpC-type beta-lactamase in two Citrobacter freundii clinical isolates. Microbial drug resistance (Larchmont, N.Y.), 2005,Fall, Volume: 11, Issue:3 Topics: 2,4-Dinitrophenol; beta-Lactamases; beta-Lactams; Ciprofloxacin; Citrobacter freundii; Drug Resistance, Bacterial; Enzyme Induction; Humans; Salicylates	2005
Factor V inhibitor: case report. Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis, 2006, Volume: 17, Issue:7 Topics: Aged; Anti-Bacterial Agents; beta-Lactams; Blood Coagulation Tests; Ciprofloxacin; Disease Progression; Factor V; Humans; Immunosuppressive Agents; Intracranial Hemorrhages; Lung Diseases; Male; Postoperative Complications	2006
Safety and effectiveness of a preoperative allergy clinic in decreasing vancomycin use in patients with a history of penicillin allergy. Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology, 2006, Volume: 97, Issue:5 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Antibiotic Prophylaxis; beta-Lactams; Cefazolin; Ceftriaxone; Cephalosporins; Ciprofloxacin; Clindamycin; Critical Pathways; Drug Hypersensitivity; Female; Humans; Male; Middle Aged; Penicillins; Preoperative Care; Skin Tests; Treatment Outcome; Vancomycin	2006
[Bilophila wadsworthia isolated from surgical specimens]. The Japanese journal of antibiotics, 2006, Volume: 59, Issue:6 Topics: Anti-Bacterial Agents; beta-Lactams; Bilophila; Ciprofloxacin; Clindamycin; Digestive System Surgical Procedures; Drug Resistance, Bacterial; Humans; Japan; Levofloxacin; Minocycline; Ofloxacin; Peritonitis; Postoperative Complications; Specimen Handling; Surgical Wound Infection	2006
In vitro synergism of beta-lactams with ciprofloxacin and moxifloxacin against genetically distinct multidrug-resistant isolates of Pseudomonas aeruginosa. International journal of antimicrobial agents, 2008, Volume: 32, Issue:1 Topics: Anti-Bacterial Agents; Aza Compounds; beta-Lactams; Ciprofloxacin; DNA Fingerprinting; DNA, Bacterial; Drug Resistance, Multiple, Bacterial; Drug Synergism; Electrophoresis, Gel, Pulsed-Field; Fluoroquinolones; Microbial Viability; Moxifloxacin; Pseudomonas aeruginosa; Pseudomonas Infections; Quinolines; Time Factors	2008
Expansion and countrywide dissemination of ST11, ST15 and ST147 ciprofloxacin-resistant CTX-M-15-type beta-lactamase-producing Klebsiella pneumoniae epidemic clones in Hungary in 2005--the new 'MRSAs'? The Journal of antimicrobial chemotherapy, 2008, Volume: 62, Issue:5 Topics: Adult; Anti-Bacterial Agents; Bacterial Typing Techniques; beta-Lactamases; beta-Lactams; Ciprofloxacin; Cluster Analysis; Conjugation, Genetic; Cross Infection; Disease Outbreaks; DNA Fingerprinting; DNA, Bacterial; Drug Resistance, Multiple, Bacterial; Electrophoresis, Gel, Pulsed-Field; Genotype; Humans; Hungary; Klebsiella Infections; Klebsiella pneumoniae; Molecular Epidemiology; Plasmids; Polymerase Chain Reaction; Polymorphism, Restriction Fragment Length; Sequence Analysis, DNA	2008
[Optimization of antibiotics in combination]. Zhonghua shao shang za zhi = Zhonghua shaoshang zazhi = Chinese journal of burns, 2008, Volume: 24, Issue:2 Topics: Amikacin; Anti-Bacterial Agents; beta-Lactams; Burn Units; Ciprofloxacin; Drug Therapy, Combination; Humans; Intensive Care Units; Microbial Sensitivity Tests; Pseudomonas aeruginosa	2008
Evidence for qnrB1 and aac(6')-Ib-cr in CTX-M-15-producing uropathogenic Enterobacteriaceae in an Italian teaching hospital. Diagnostic microbiology and infectious disease, 2009, Volume: 64, Issue:1 Topics: Aminoglycosides; Anti-Bacterial Agents; beta-Lactamases; beta-Lactams; Ciprofloxacin; Drug Resistance, Multiple, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Gene Order; Genes, Bacterial; Hospitals, Teaching; Humans; Italy; Urinary Tract Infections	2009
Subinhibitory fluoroquinolone exposure selects for reduced beta-lactam susceptibility in methicillin-resistant Staphylococcus aureus and alterations in the SOS-mediated response. Research in microbiology, 2009, Volume: 160, Issue:3 Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactam Resistance; beta-Lactams; Ciprofloxacin; Community-Acquired Infections; DNA Gyrase; DNA Mutational Analysis; DNA Transposable Elements; Fluoroquinolones; Gene Expression Profiling; Humans; Levofloxacin; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Nafcillin; Ofloxacin; Penicillin-Binding Proteins; Selection, Genetic; SOS Response, Genetics; Staphylococcal Infections; Transcription Factors; Up-Regulation	2009
Previous ciprofloxacin exposure is associated with resistance to beta-lactam antibiotics in subsequent Pseudomonas aeruginosa bacteremic isolates. American journal of infection control, 2009, Volume: 37, Issue:9 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacteremia; beta-Lactam Resistance; beta-Lactams; Ciprofloxacin; Female; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Pseudomonas aeruginosa; Pseudomonas Infections; Young Adult	2009
Nursing homes as a reservoir of extended-spectrum beta-lactamase (ESBL)-producing ciprofloxacin-resistant Escherichia coli. The Journal of antimicrobial chemotherapy, 2009, Volume: 64, Issue:3 Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; beta-Lactamases; beta-Lactams; Carrier State; Ciprofloxacin; Drug Resistance, Multiple, Bacterial; Escherichia coli; Escherichia coli Infections; Feces; Female; Humans; Male; Northern Ireland; Nursing Homes; Prevalence	2009
Activity of amikacin, ertapenem, ciprofloxacin and levofloxacin alone and in combination against resistant nosocomial pathogens by time-kill. The West Indian medical journal, 2008, Volume: 57, Issue:2 Topics: Amikacin; Anti-Bacterial Agents; beta-Lactams; Ciprofloxacin; Cross Infection; Drug Synergism; Drug Therapy, Combination; Ertapenem; Gram-Negative Bacteria; Gram-Positive Cocci; Humans; Levofloxacin; Microbial Sensitivity Tests; Ofloxacin	2008
Outbreaks of imipenem resistant Acinetobacter baumannii producing OXA-23 beta-lactamase in a tertiary care hospital in Korea. Yonsei medical journal, 2009, Dec-31, Volume: 50, Issue:6 Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; beta-Lactamases; beta-Lactams; Cefepime; Cephalosporins; Ciprofloxacin; Disease Outbreaks; Drug Resistance, Multiple, Bacterial; Electrophoresis, Gel, Pulsed-Field; Gentamicins; Humans; Imipenem; Korea; Microbial Sensitivity Tests	2009
Rapidly spreading CTX-M-type beta-lactamase-producing Proteus mirabilis in Japan. International journal of antimicrobial agents, 2010, Volume: 36, Issue:4 Topics: Anti-Bacterial Agents; Bacterial Typing Techniques; beta-Lactamases; beta-Lactams; Ciprofloxacin; DNA, Bacterial; Drug Resistance, Bacterial; Electrophoresis, Gel, Pulsed-Field; Humans; Japan; Microbial Sensitivity Tests; Molecular Epidemiology; Polymerase Chain Reaction; Prevalence; Proteus Infections; Proteus mirabilis; Quinolones; Sequence Analysis, DNA; Time Factors	2010
Antimicrobial susceptibility of Neisseria meningitidis strains isolated from meningitis cases in Brazil from 2006 to 2008. Enfermedades infecciosas y microbiologia clinica, 2011, Volume: 29, Issue:2 Topics: Adolescent; Adult; Anti-Bacterial Agents; beta-Lactams; Brazil; Child; Child, Preschool; Chloramphenicol; Ciprofloxacin; Drug Resistance, Multiple, Bacterial; Female; Humans; Infant; Male; Meningitis, Meningococcal; Microbial Sensitivity Tests; Neisseria meningitidis; Rifampin; Serotyping; Species Specificity; Young Adult	2011
Drug induced immune haemolytic anaemia in the Berlin Case-Control Surveillance Study. British journal of haematology, 2011, Volume: 154, Issue:5 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anemia, Hemolytic, Autoimmune; Anti-Bacterial Agents; Anti-Inflammatory Agents, Non-Steroidal; Antineoplastic Agents; Berlin; beta-Lactams; Case-Control Studies; Ciprofloxacin; Diclofenac; Drug-Related Side Effects and Adverse Reactions; Female; Humans; Lorazepam; Male; Middle Aged; Odds Ratio; Piperacillin; Population Surveillance; Trimethoprim, Sulfamethoxazole Drug Combination; Vidarabine; Young Adult	2011
Development of carbapenem resistance during therapy for non-typhoid Salmonella infection. Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases, 2012, Volume: 18, Issue:4 Topics: Aged; Anti-Bacterial Agents; beta-Lactams; Carbapenems; Ciprofloxacin; Drug Resistance, Multiple, Bacterial; Ertapenem; Feces; Female; Humans; Microbial Sensitivity Tests; Plasmids; Point Mutation; Porins; RNA, Bacterial; Salmonella Infections; Salmonella typhimurium; Urinary Tract Infections; Wound Infection	2012
Comparison of the WST-8 colorimetric method and the CLSI broth microdilution method for susceptibility testing against drug-resistant bacteria. Journal of microbiological methods, 2012, Volume: 90, Issue:3 Topics: Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactams; Ciprofloxacin; Colorimetry; Culture Media; Enterococcus faecalis; Haemophilus influenzae; Indicator Dilution Techniques; Klebsiella pneumoniae; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Microbial Viability; Pseudomonas aeruginosa; Vancomycin; Vancomycin Resistance	2012
Integrons, β-lactamase and qnr genes in multidrug resistant clinical isolates of Proteus mirabilis and P. vulgaris. APMIS : acta pathologica, microbiologica, et immunologica Scandinavica, 2012, Volume: 120, Issue:12 Topics: Anti-Bacterial Agents; beta-Lactamases; beta-Lactams; Ciprofloxacin; DNA, Bacterial; Drug Resistance, Multiple, Bacterial; Fluoroquinolones; Gentamicins; Humans; Integrons; Microbial Sensitivity Tests; Molecular Sequence Data; Proteus mirabilis; Proteus vulgaris; Sequence Analysis, DNA; Sulfamethoxazole; Trimethoprim, Sulfamethoxazole Drug Combination	2012
Impact of ertapenem use on Pseudomonas aeruginosa and Acinetobacter baumannii imipenem susceptibility rates: collateral damage or positive effect on hospital ecology? The Journal of antimicrobial chemotherapy, 2013, Volume: 68, Issue:8 Topics: Acinetobacter baumannii; Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactams; Ciprofloxacin; Cross Infection; Drug Utilization; Ecosystem; Ertapenem; Humans; Imipenem; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Retrospective Studies; Selection, Genetic; Tertiary Care Centers	2013
Sublethal ciprofloxacin treatment leads to rapid development of high-level ciprofloxacin resistance during long-term experimental evolution of Pseudomonas aeruginosa. Antimicrobial agents and chemotherapy, 2013, Volume: 57, Issue:9 Topics: Anti-Bacterial Agents; beta-Lactams; Ciprofloxacin; DNA Gyrase; Dose-Response Relationship, Drug; Drug Resistance, Multiple, Bacterial; Microbial Sensitivity Tests; Mutation; Pseudomonas aeruginosa; Sequence Analysis, DNA	2013
Activity of the antiseptic polyhexanide against gram-negative bacteria. Microbial drug resistance (Larchmont, N.Y.), 2014, Volume: 20, Issue:2 Topics: Anti-Bacterial Agents; Anti-Infective Agents, Local; beta-Lactams; Biguanides; Ciprofloxacin; Drug Combinations; Escherichia coli; Gentamicins; Haemophilus influenzae; Klebsiella pneumoniae; Microbial Sensitivity Tests; Microbial Viability; Moraxella catarrhalis; Pseudomonas aeruginosa	2014
Risk factors associated with preoperative fecal carriage of extended-spectrum β-lactamase-producing Enterobacteriaceae in liver transplant recipients. Transplant infectious disease : an official journal of the Transplantation Society, 2014, Volume: 16, Issue:1 Topics: Adult; Amikacin; beta-Lactamases; beta-Lactams; Cefoxitin; Ciprofloxacin; Drug Resistance, Bacterial; End Stage Liver Disease; Enterobacter cloacae; Enterobacteriaceae; Enterobacteriaceae Infections; Escherichia coli; Escherichia coli Infections; Feces; Female; Humans; Imipenem; Klebsiella; Klebsiella Infections; Klebsiella pneumoniae; Liver Transplantation; Logistic Models; Male; Microbial Sensitivity Tests; Middle Aged; Multivariate Analysis; Penicillanic Acid; Peritonitis; Piperacillin; Piperacillin, Tazobactam Drug Combination; Preoperative Period; Risk Factors; Severity of Illness Index	2014
Ertapenem prophylaxis reduces sepsis after transrectal biopsy of the prostate. BJU international, 2014, Volume: 113 Suppl 2 Topics: Aged; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Antibiotic Prophylaxis; beta-Lactams; Biopsy; Ciprofloxacin; Drug Therapy, Combination; Ertapenem; Escherichia coli Infections; Humans; Male; Middle Aged; Patient Selection; Prospective Studies; Prostatic Neoplasms; Rectum; Risk Assessment; Risk Factors; Sepsis; Surveys and Questionnaires; Treatment Outcome; Ultrasonography, Interventional	2014
Multidrug-resistant Escherichia coli soft tissue infection investigated with bacterial whole genome sequencing. BMJ case reports, 2014, Oct-19, Volume: 2014 Topics: Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; beta-Lactams; Ciprofloxacin; Diagnosis, Differential; Drug Resistance, Multiple, Bacterial; Ertapenem; Escherichia coli; Escherichia coli Infections; Floxacillin; Follow-Up Studies; Genome, Bacterial; Gentamicins; Humans; Liver Diseases; Male; Meropenem; Middle Aged; Sequence Analysis, DNA; Soft Tissue Infections; Thienamycins; Treatment Outcome; Vancomycin	2014
Characterization of antibiotic and disinfectant susceptibility profiles among Pseudomonas aeruginosa veterinary isolates recovered during 1994-2003. Journal of applied microbiology, 2015, Volume: 118, Issue:2 Topics: Animals; Anti-Bacterial Agents; beta-Lactams; Ciprofloxacin; Disinfectants; Dogs; Drug Resistance, Bacterial; Enrofloxacin; Fluoroquinolones; Pseudomonas aeruginosa	2015
Antimicrobial Susceptibilities of Aerobic and Facultative Gram-Negative Bacilli from Intra-abdominal Infections in Patients from Seven Regions in China in 2012 and 2013. Antimicrobial agents and chemotherapy, 2016, Volume: 60, Issue:1 Topics: Amikacin; Ampicillin; Anti-Bacterial Agents; beta-Lactamases; beta-Lactams; Cefoxitin; China; Ciprofloxacin; Community-Acquired Infections; Cross Infection; Drug Resistance, Multiple, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Ertapenem; Gene Expression; Humans; Imipenem; Intraabdominal Infections; Levofloxacin; Microbial Sensitivity Tests; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Sulbactam	2016
Patterns of Multi-Antibiotic-Resistant Escherichia Coli from Streams with No History of Antimicrobial Inputs. Microbial ecology, 2016, Volume: 72, Issue:4 Topics: Aminoglycosides; Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactams; Ciprofloxacin; Drug Combinations; Drug Resistance, Multiple, Bacterial; Escherichia coli; Fluoroquinolones; Gatifloxacin; Geologic Sediments; Microbial Sensitivity Tests; Rivers; Water Microbiology	2016
Prevalence of bla TEM-220 gene in Penicillinase-producing Neisseria gonorrhoeae strains carrying Toronto/Rio plasmid in Argentina, 2002 - 2011. BMC infectious diseases, 2015, Dec-16, Volume: 15 Topics: Anti-Bacterial Agents; Argentina; beta-Lactamases; beta-Lactams; Ciprofloxacin; Humans; Microbial Sensitivity Tests; Mutation; Neisseria gonorrhoeae; Penicillinase; Plasmids; Prevalence	2015
Small angle X-ray scattering as a high-throughput method to classify antimicrobial modes of action. Biochimica et biophysica acta, 2016, Volume: 1858, Issue:5 Topics: Aminoglycosides; Anti-Bacterial Agents; Antimicrobial Cationic Peptides; beta-Lactams; Chloramphenicol; Ciprofloxacin; Drug Discovery; Escherichia coli K12; High-Throughput Screening Assays; Microscopy, Electron, Transmission; Polymyxin B; Principal Component Analysis; Rifampin; Scattering, Small Angle; Tetracycline; X-Ray Diffraction	2016
Place of diagnostic tools in the identification of Anaerobiospirillum succiniciproducens bacteraemia. Anaerobe, 2016, Volume: 39 Topics: Anaerobiospirillum; Anti-Bacterial Agents; beta-Lactams; Ciprofloxacin; Clindamycin; Delayed Diagnosis; Drug Resistance, Bacterial; Gram-Negative Bacterial Infections; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Pelvis; RNA, Ribosomal, 16S; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization	2016
Dynamics of Mutations during Development of Resistance by Pseudomonas aeruginosa against Five Antibiotics. Antimicrobial agents and chemotherapy, 2016, Volume: 60, Issue:7 Topics: Anti-Bacterial Agents; beta-Lactamases; beta-Lactams; Ceftazidime; Ciprofloxacin; DNA Gyrase; DNA Topoisomerase IV; Drug Resistance, Microbial; Meropenem; Microbial Sensitivity Tests; Mutation; Piperacillin; Pseudomonas aeruginosa; Thienamycins; Tobramycin	2016
An Immunocompromised Child with Bloodstream Infection Caused by Two Escherichia coli Strains, One Harboring NDM-5 and the Other Harboring OXA-48-Like Carbapenemase. Antimicrobial agents and chemotherapy, 2016, Volume: 60, Issue:6 Topics: Adolescent; Amikacin; Anti-Bacterial Agents; Aztreonam; Bacterial Proteins; beta-Lactamases; beta-Lactams; Ciprofloxacin; Ertapenem; Escherichia coli; Female; Gentamicins; Humans; Immunocompromised Host; Meropenem; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Tazobactam; Thienamycins; Tobramycin	2016
Risk factors for hospital-acquired bacteremia due to carbapenem-resistant Pseudomonas aeruginosa in a Colombian hospital. Biomedica : revista del Instituto Nacional de Salud, 2016, Feb-23, Volume: 36, Issue:0 Topics: Bacteremia; beta-Lactams; Carbapenems; Case-Control Studies; Ciprofloxacin; Drug Resistance, Bacterial; Ertapenem; Hospitals; Humans; Meropenem; Pseudomonas aeruginosa; Pseudomonas Infections; Risk Factors; Thienamycins	2016
Multidrug-Resistant Pseudomonas aeruginosa Infection in a Child with Cystic Fibrosis. Antimicrobial agents and chemotherapy, 2016, Volume: 60, Issue:10 Topics: Adolescent; Amikacin; Anti-Bacterial Agents; beta-Lactams; Ciprofloxacin; Cystic Fibrosis; Drug Hypersensitivity; Drug Resistance, Multiple, Bacterial; Drug Therapy, Combination; Female; Humans; Microbial Sensitivity Tests; Penicillanic Acid; Pseudomonas aeruginosa; Pseudomonas Infections; Tazobactam	2016
Occurrences and Characterization of Antibiotic-Resistant Bacteria and Genetic Determinants of Hospital Wastewater in a Tropical Country. Antimicrobial agents and chemotherapy, 2016, Volume: 60, Issue:12 Topics: Amikacin; Anti-Bacterial Agents; Bacteria; beta-Lactamases; beta-Lactams; Chromatography, Liquid; Ciprofloxacin; Drug Resistance, Microbial; Escherichia coli Proteins; Hospitals; Humans; Integrases; Singapore; Tandem Mass Spectrometry; Trimethoprim, Sulfamethoxazole Drug Combination; Wastewater	2016
Transrectal ultrasound guided prostate biopsy in the era of increasing fluoroquinolone resistance: prophylaxis with single-dose ertapenem. World journal of urology, 2017, Volume: 35, Issue:11 Topics: Aged; Anti-Bacterial Agents; Antibiotic Prophylaxis; beta-Lactams; Biopsy, Large-Core Needle; Ciprofloxacin; Endosonography; Ertapenem; Humans; Image-Guided Biopsy; Male; Middle Aged; Prostate; Retrospective Studies; Surgical Wound Infection; Urinary Tract Infections	2017
Patterns of antimicrobial resistance in intensive care unit patients: a study in Vietnam. BMC infectious diseases, 2017, 06-15, Volume: 17, Issue:1 Topics: Acinetobacter baumannii; Acinetobacter Infections; Aged; Anti-Bacterial Agents; beta-Lactams; Ceftazidime; Ciprofloxacin; Drug Resistance, Bacterial; Ertapenem; Female; Humans; Imipenem; Intensive Care Units; Klebsiella; Male; Microbial Sensitivity Tests; Middle Aged; Pneumonia, Ventilator-Associated; Pseudomonas aeruginosa; Pseudomonas Infections; Vietnam	2017
First Description of bla Microbial drug resistance (Larchmont, N.Y.), 2018, Volume: 24, Issue:2 Topics: Aminoglycosides; Anti-Bacterial Agents; beta-Lactamases; beta-Lactams; Ciprofloxacin; Drug Resistance, Multiple, Bacterial; Escherichia coli; Escherichia coli Infections; Escherichia coli Proteins; Gene Expression; Genes, Bacterial; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Multilocus Sequence Typing; Pakistan; Plasmids; Spain; Travel	2018
Reducing Second Gram-Negative Antibiotic Therapy on Pediatric Oncology and Hematopoietic Stem Cell Transplantation Services. Infection control and hospital epidemiology, 2017, Volume: 38, Issue:9 Topics: Adolescent; Anti-Bacterial Agents; Antimicrobial Stewardship; beta-Lactams; Child; Child, Preschool; Ciprofloxacin; Drug Combinations; Drug Utilization; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Guidelines as Topic; Hematopoietic Stem Cell Transplantation; Hospitals, Pediatric; Humans; Length of Stay; Medical Oncology; Neutropenia; Pediatrics; Poisson Distribution; San Francisco; Tobramycin; Treatment Outcome	2017
Clinical and molecular features of MDR livestock-associated MRSA ST9 with staphylococcal cassette chromosome mecXII in humans. The Journal of antimicrobial chemotherapy, 2018, Jan-01, Volume: 73, Issue:1 Topics: Adult; Aged; Aged, 80 and over; Animals; Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactams; Child, Preschool; Ciprofloxacin; Clindamycin; Drug Resistance, Multiple, Bacterial; Erythromycin; Farmers; Female; Gentamicins; Humans; Livestock; Male; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Middle Aged; Minocycline; Staphylococcal Infections; Swine; Swine Diseases; Taiwan; Tigecycline; Virginiamycin	2018
Is fluoroquinolone monotherapy a useful alternative treatment for Pseudomonas aeruginosa bacteraemia? Infection, 2018, Volume: 46, Issue:3 Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacteremia; beta-Lactams; Ciprofloxacin; Cohort Studies; Female; Fluoroquinolones; Humans; Levofloxacin; Male; Middle Aged; Pseudomonas aeruginosa; Pseudomonas Infections; Retrospective Studies; Risk Factors; Taiwan; Treatment Outcome	2018
Environmental superbugs: The case study of Pedobacter spp. Environmental pollution (Barking, Essex : 1987), 2018, Volume: 241 Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; beta-Lactams; Ciprofloxacin; Drug Resistance, Microbial; Ertapenem; Escherichia coli; Humans; Meropenem; Microbial Sensitivity Tests; Pedobacter; Thienamycins	2018
Rapid antimicrobial susceptibility testing and β-lactam-induced cell morphology changes of Gram-negative biological threat pathogens by optical screening. BMC microbiology, 2018, 12-18, Volume: 18, Issue:1 Topics: Anti-Bacterial Agents; beta-Lactams; Burkholderia mallei; Burkholderia pseudomallei; Ciprofloxacin; Doxycycline; Glanders; Humans; Imipenem; Melioidosis; Microbial Sensitivity Tests; Plague; Time-Lapse Imaging; Yersinia pestis	2018
Examination of Aggregate Formation upon Simultaneous Dissolution of Methacrylic Acid Copolymer LD Enteric Coating Agent, Pharmaceutical Additives, and Zwitterionic Ingredients. Biological & pharmaceutical bulletin, 2020, Volume: 43, Issue:4 Topics: Anti-Bacterial Agents; beta-Lactams; Ciprofloxacin; Drug Liberation; Ofloxacin; Polymethacrylic Acids; Static Electricity; Sulfur Compounds; Tablets, Enteric-Coated; Tegafur	2020
Novel enterocin E20c purified from Enterococcus hirae 20c synergised with ß-lactams and ciprofloxacin against Salmonella enterica. Microbial cell factories, 2020, May-04, Volume: 19, Issue:1 Topics: Anti-Bacterial Agents; Bacteriocins; beta-Lactams; Bridged-Ring Compounds; Cell Membrane; Cell Membrane Permeability; Ciprofloxacin; Drug Resistance, Multiple, Bacterial; Drug Synergism; Enterococcus hirae; Gram-Negative Bacteria; Microbial Sensitivity Tests; Salmonella enterica	2020
Efficacy and Therapeutic Drug Monitoring of Continuous Beta-Lactam Infusion for Osteoarticular Infections Caused by Fluoroquinolone-Resistant Pseudomonas aeruginosa: A Prospective Cohort Study. European journal of drug metabolism and pharmacokinetics, 2020, Volume: 45, Issue:5 Topics: Aged; Anti-Bacterial Agents; beta-Lactams; Bone Diseases, Infectious; Ciprofloxacin; Cohort Studies; Colistin; Drug Monitoring; Drug Resistance, Multiple, Bacterial; Female; Humans; Infusions, Intravenous; Joint Diseases; Male; Microbial Sensitivity Tests; Middle Aged; Prospective Studies; Pseudomonas aeruginosa; Pseudomonas Infections	2020
Investigations on Synergistic and Antioxidant Actions of Medicinal Plant- Based Biosynthesis of Zinc Oxide Nanoparticles Against E.coli and K. pneumonia Bacteria. Combinatorial chemistry & high throughput screening, 2022, Volume: 25, Issue:7 Topics: Anti-Bacterial Agents; Antioxidants; Bacteria; beta-Lactams; Ciprofloxacin; Escherichia coli; Metal Nanoparticles; Microbial Sensitivity Tests; Nanoparticles; Plant Extracts; Plants, Medicinal; Pneumonia; Zinc Oxide	2022
Global protein responses of multidrug resistance plasmid-containing Escherichia coli to ampicillin, cefotaxime, imipenem and ciprofloxacin. Journal of global antimicrobial resistance, 2022, Volume: 28 Topics: Ampicillin; Anti-Bacterial Agents; Anti-Infective Agents; beta-Lactamases; beta-Lactams; Cefotaxime; Ciprofloxacin; Drug Resistance, Multiple; Escherichia coli; Imipenem; Plasmids; Proteome; Proteomics	2022
Prevalence and molecular characterization of foodborne and human-derived Salmonella strains for resistance to critically important antibiotics. Transboundary and emerging diseases, 2022, Volume: 69, Issue:5 Topics: Aminoglycosides; Animals; Anti-Bacterial Agents; beta-Lactamases; beta-Lactams; Carbapenems; Cattle; Cephalosporins; Ciprofloxacin; Colistin; Cross-Sectional Studies; Drug Resistance, Multiple, Bacterial; Humans; Microbial Sensitivity Tests; Monobactams; Prevalence; Rabbits; Salmonella; Salmonella enterica; Tetracyclines	2022
Barriers and facilitators for therapeutic drug monitoring of beta-lactams and ciprofloxacin in the ICU: a nationwide cross-sectional study. BMC infectious diseases, 2022, Jul-13, Volume: 22, Issue:1 Topics: Anti-Bacterial Agents; beta-Lactams; Ciprofloxacin; Cross-Sectional Studies; Drug Monitoring; Humans; Intensive Care Units	2022
Single Cell Killing Kinetics Differentiate Phenotypic Bacterial Responses to Different Antibacterial Classes. Microbiology spectrum, 2023, 02-14, Volume: 11, Issue:1 Topics: Ampicillin; Anti-Bacterial Agents; Bacteria; beta-Lactams; Ciprofloxacin; Escherichia coli; Fluoroquinolones; Microbial Sensitivity Tests	2023
YgfB increases β-lactam resistance in Pseudomonas aeruginosa by counteracting AlpA-mediated ampDh3 expression. Communications biology, 2023, 03-10, Volume: 6, Issue:1 Topics: beta-Lactam Resistance; beta-Lactams; Ciprofloxacin; Pseudomonas aeruginosa	2023
Seasonal analysis of commonly prescribed antibiotics in Istanbul city. Environmental monitoring and assessment, 2023, Apr-14, Volume: 195, Issue:5 Topics: Anti-Bacterial Agents; beta-Lactams; Chromatography, Liquid; Ciprofloxacin; Clarithromycin; Environmental Monitoring; Seasons; Sewage; Solid Phase Extraction; Tandem Mass Spectrometry; Wastewater; Water Pollutants, Chemical	2023
Prophage Gifsy-1 Induction in Salmonella enterica Serovar Typhimurium Reduces Persister Cell Formation after Ciprofloxacin Exposure. Microbiology spectrum, 2023, 08-17, Volume: 11, Issue:4 Topics: Anti-Bacterial Agents; beta-Lactams; Ciprofloxacin; DNA Gyrase; Prophages; Salmonella enterica; Salmonella typhimurium; Serogroup	2023